Baxter International Faces Class Action Lawsuit Over Novum LVP Product Defects
- Baxter International faces class action lawsuits for allegedly misleading investors about the safety of its Novum LVP product.
- The lawsuits claim Baxter knew about serious malfunctions and failed to address ongoing design flaws adequately.
- Shareholders affected by Baxter's alleged deceptive practices are encouraged to participate in the class action lawsuit by December 15, 2025.
Baxter International Faces Class Action Over Alleged Product Defects
Baxter International, Inc. finds itself embroiled in legal challenges as multiple law firms announce class action lawsuits alleging securities fraud linked to its Novum LVP product. The lawsuits, initiated by The Gross Law Firm, Levi & Korsinsky, LLP, and Glancy Prongay & Murray LLP, target the company for purportedly misleading investors about the safety and efficacy of the Novum LVP, which is designed for intravenous fluid delivery. Between February 23, 2022, and July 30, 2025, Baxter allegedly made materially false statements regarding the product, which has reportedly experienced systemic defects leading to serious malfunctions, including underinfusion and overinfusion. These issues raise significant concerns regarding patient safety and trust in Baxter's medical devices.
The lawsuits contend that Baxter was aware of multiple incidents involving malfunctions, injuries, and even fatalities associated with the Novum LVP. Despite this knowledge, the company's responses, including customer alerts, are deemed insufficient to address the ongoing design flaws. The allegations suggest that the company failed to take adequate remedial measures, which may lead to customers withdrawing existing Novum LVPs from service and a halt in new sales. Consequently, Baxter's communications regarding the product's safety, efficacy, and market viability are considered misleading, potentially impacting not only patient safety but also the company's financial health.
Shareholders who purchased Baxter's stock during the specified period are encouraged to participate in the class action lawsuit, with a deadline to register by December 15, 2025. Participation incurs no costs, and registered shareholders will receive updates regarding the case. The law firms involved emphasize their commitment to advocating for investors' rights against alleged corporate malpractice, aiming to facilitate recovery for those who have incurred losses due to Baxter's purported deceptive practices.
In related news, Dr. Walter Jacobson, a psychiatrist and first-time filmmaker, garners attention at the 2025 American Film Market Pitch Conference with his comedy "Baxter's Brain," which critiques the medical field and societal absurdities. His engaging pitch earns third place among 150 entries, showcasing a juxtaposition of creative success amid Baxter's ongoing legal issues.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

